By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)

SHZ Currency in CNY
¥10.17
-¥0.09
-0.88%
Last Update: 29 Aug 2025, 07:04
¥3.09B
Market Cap
63.01
P/E Ratio (TTM)
0.39%
Forward Dividend Yield
¥6.85 - ¥12.90
52 Week Range

300534.SZ Stock Price Chart

Explore Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD interactive price chart. Choose custom timeframes to analyze 300534.SZ price movements and trends.

300534.SZ Company Profile

Discover essential business fundamentals and corporate details for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

13 Sept 2016

Employees

634.00

CEO

Qin Hui Yuan

Description

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines, health food, and APIs. It offers Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, and Astragalus Angelica capsules, as well as berberine tannin films. The company also engages in the planting, acquisition, processing, sales, and commercial distribution of Chinese medicinal materials; investment and management of project; and import, sales, logistics, and export of pharmaceutical. Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd was founded in 2002 and is based in Lanzhou, China.

300534.SZ Financial Timeline

Browse a chronological timeline of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 28 May 2025

A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 28 May 2025.

Earnings released on 15 May 2025

EPS came in at ¥0.00 , while revenue for the quarter reached ¥232.86M .

Earnings released on 31 Mar 2025

EPS came in at ¥0.08 , while revenue for the quarter reached ¥289.44M .

Earnings released on 29 Sept 2024

EPS came in at ¥0.01 , while revenue for the quarter reached ¥255.38M .

Dividend declared on 27 Sept 2024

A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 27 Sept 2024.

Earnings released on 29 Jun 2024

EPS came in at -¥0.00 , while revenue for the quarter reached ¥291.89M .

Dividend declared on 6 Jun 2024

A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 6 Jun 2024.

Earnings released on 15 May 2024

EPS came in at ¥0.07 , while revenue for the quarter reached ¥254.91M .

Earnings released on 26 Feb 2024

EPS came in at ¥0.05 , while revenue for the quarter reached ¥267.74M .

Earnings released on 3 Jan 2024

EPS came in at ¥0.05 , while revenue for the quarter reached ¥220.83M .

Earnings released on 30 Jun 2023

EPS came in at ¥0.04 , while revenue for the quarter reached ¥295.15M .

Earnings released on 31 Mar 2023

EPS came in at ¥0.07 , while revenue for the quarter reached ¥296.32M .

Earnings released on 1 Jan 2023

EPS came in at ¥0.08 , while revenue for the quarter reached ¥398.58M .

Earnings released on 30 Sept 2022

EPS came in at ¥0.01 , while revenue for the quarter reached ¥73.11M .

Earnings released on 30 Jun 2022

EPS came in at ¥0.00 , while revenue for the quarter reached ¥95.12M .

Earnings released on 31 Mar 2022

EPS came in at ¥0.00 , while revenue for the quarter reached ¥55.26M .

Earnings released on 31 Dec 2021

EPS came in at -¥0.00 , while revenue for the quarter reached ¥121.13M .

Earnings released on 30 Sept 2021

EPS came in at -¥0.03 , while revenue for the quarter reached ¥59.00M .

Earnings released on 30 Jun 2021

EPS came in at ¥0.00 , while revenue for the quarter reached ¥58.53M .

Earnings released on 29 Apr 2021

EPS came in at ¥0.05 , while revenue for the quarter reached ¥86.96M .

Earnings released on 31 Mar 2021

EPS came in at ¥0.00 , while revenue for the quarter reached ¥49.15M .

Earnings released on 30 Sept 2020

EPS came in at -¥0.01 , while revenue for the quarter reached ¥72.45M .

300534.SZ Stock Performance

Access detailed 300534.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run